About: Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence
Creator	Ghosn, Marwan Moujaess, Elissar Kourie, Raphael
Source	Elsevier; Medline; PMC
abstract	The novel coronavirus, also known as SARS-Cov-2 or COVID-19 has become a worldwide threat and the major healthcare concern of the year 2020. Cancer research was directly affected by the emerging of this disease. According to some Chinese studies, cancer patients are more vulnerable to COVID-19 complications. This observation led many oncologists to change their daily practice in cancer care, without solid evidence and recommendations. Moreover, the COVID-19 manifestations as well as its diagnosis are particular in this special population. In this review paper we expose the challenges of cancer management in the era of SARS-CoV-2, the epidemiological, clinical, pathological and radiological characteristics of the disease in cancer patients and its outcomes on this population. Finally, we focus on strategies that are followed in cancer management with review of national and international guidelines.
has issue date	2020-04-22(xsd:dateTime)
bibo:doi	10.1016/j.critrevonc.2020.102972
bibo:pmid	32344317
has license	no-cc
sha1sum (hex)	ad5abad2c6fb3775437f7aa725cd78995f5f3bba
schema:url	https://doi.org/10.1016/j.critrevonc.2020.102972
resource representing a document's title	Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence
has PubMed Central identifier	PMC7174983
has PubMed identifier	32344317
schema:publication	Crit Rev Oncol Hematol
resource representing a document's body	covid:ad5abad2c6fb3775437f7aa725cd78995f5f3bba#body_text
is schema:about of	named entity 'observation' named entity 'cancer' named entity 'coronavirus' named entity 'ONCOLOGISTS' named entity 'REVIEW OF' named entity 'DIAGNOSIS' named entity 'NOVEL CORONAVIRUS' named entity 'FOCUS' named entity 'CHARACTERISTICS' named entity 'PARTICULAR' named entity 'GUIDELINES' named entity 'CHALLENGES' named entity 'emerging' named entity 'cancer' named entity 'population' named entity 'strategies' named entity 'pathological' named entity 'expose' named entity 'cancer care' named entity 'COVID' named entity 'COVID-19' named entity 'Cancer patients' named entity 'Cancer patients' named entity 'COVID-19' named entity 'oncology' named entity 'oncological diseases' named entity 'asymptomatic patients' named entity 'viral infection' named entity 'Italy' named entity 'mortality rate' named entity 'risk of transmission' named entity 'Singapore' named entity 'COVID' named entity 'case series' named entity 'infection' named entity 'higher risk' named entity 'COVID' named entity 'neoplasm' named entity 'respiratory droplets' named entity 'cancer care' named entity 'hospital settings' named entity 'tumors' named entity 'infection' named entity 'endoscopic' named entity 'Italy' named entity 'COVID-19' named entity 'Hepatitis' named entity 'comorbid conditions' named entity 'Italian' named entity 'RT-PCR' named entity 'infection' named entity 'Italian' named entity 'cross-sectional analysis' named entity 'PD-1 inhibitor' named entity 'SARS-CoV-2' named entity 'CT-scan' named entity 'healthcare workers' named entity 'COVID-19' named entity 'French language' named entity 'Tuscany' named entity 'COVID-19 pandemic' named entity 'comorbid conditions' named entity '95% CI' named entity 'April 2020' named entity 'viruses' named entity 'infection' named entity 'comorbidities' named entity 'psychosocial' named entity 'clinical features' named entity 'urology' named entity 'incidental findings' named entity 'cancer care' named entity 'lung cancer' named entity 'radiographic' named entity 'imaging studies' named entity 'asymptomatic' named entity 'ixazomib' named entity 'carfilzomib' named entity 'mechanical ventilation'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software